Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/1995
11/30/1995WO1995032218A1 Neurotensin antagonist peptides
11/30/1995WO1995032217A1 Peptide antagonist intermediates of neurotensin
11/30/1995WO1995032209A1 AZABICYCLOALKYL DERIVATIVES OF IMIDAZO(1,5-a)INDOL-3-ONE AS 5HT3 ANTAGONISTS
11/30/1995WO1995032208A1 IMIDAZOLYLALKYL DERIVATIVES OF IMIDAZOL(5,1-c)(1,4)BENZOXAZIN-1-ONE AND THEIR USE AS THERAPEUTIC AGENTS
11/30/1995WO1995032205A1 Tricyclic dicarbonyl derivatives
11/30/1995WO1995032204A1 Imidazolylalkyl derivatives of imidazo(1,5-a)indol-3-one and their use as therapeutic agents
11/30/1995WO1995032203A2 Use of tetrahydropteridine derivatives as no-synthase inhibitors
11/30/1995WO1995032197A1 Palladium catalyzed ring closure of triazolyl tryptamine
11/30/1995WO1995032196A1 Piperazine, piperidine and tetrahydropyridine derivatives of indol-3-ylalkyl as 5-ht1d-alpha agonists
11/30/1995WO1995031996A1 Materials and methods for treatment of plaquing diseases
11/30/1995WO1995031990A1 Copolymer-1 improvements in compositions of copolymers
11/30/1995WO1995031988A1 COMPOSITION CONTAINING 5HTIA and 5HTID ANTAGONISTS
11/30/1995WO1995031987A1 Use of pteridine derivatives as no-synthase inhibitors
11/30/1995WO1995031985A2 Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies
11/30/1995WO1995031976A1 Transdermal delivery of anti-epileptic drugs
11/30/1995DE4418097A1 Verwendung von Tetrahydropteridin-Derivaten als Hemmstoffe der NO-Synthase Using Tetrahydropteridin derivatives as inhibitors of NO synthase
11/30/1995DE4418096A1 Verwendung von Pteridin-Derivaten als Hemmstoffe der NO-Synthase The use of pteridine derivatives as inhibitors of NO synthase
11/30/1995CA2190501A1 Piperazine, piperidine and tetrahydropyridine derivatives of indol-3-ylalkyl as 5-ht1d-alpha agonists
11/30/1995CA2189776A1 Tricyclic dicarbonyl derivatives
11/30/1995CA2166621A1 Azabicycloalkyl derivatives of imidazo(1,5-a)indol-3-one and process for their preparation
11/30/1995CA2166619A1 Imidazolylalkyl derivatives of imidazo(1,5-a)indol-3-one and their use as therapeutic agents
11/30/1995CA2166617A1 Imidazolylalkyl derivatives of imidazol(5,1-c)(1,4)benzoxazin-1-one and their use as therapeutic agents
11/29/1995EP0684257A1 Pseudopeptide derivatives of neurokinines, process for their preparation and pharmaceutical compositions comprising them
11/29/1995EP0683781A1 Novel inhibitors of adenosine monophosphate deaminase
11/29/1995EP0683778A1 Heteroaromatic compounds with antipsychotic activity
11/29/1995EP0683775A1 Heterocyclic 4-aminomethylpiperidine derivatives, their preparation and application in therapy
11/29/1995EP0683767A1 Azacyclic compounds, compositions containing them and their use as tachykinin antagonists
11/29/1995EP0683674A1 Use of thrombine inhibitors for controlling neurodegenerative diseases
11/29/1995EP0541798B1 New diamine compound and brain protecting agent containing the same
11/29/1995EP0359783B1 Treatment of autoimmune diseases by oral administration of autoantigens
11/29/1995CN1112786A 2-amino-4-phenyl-4-oxo-butyric acid derivatives with kynureninase and/or kynurenine-3-hydroxylase inhibiting activity
11/29/1995CN1112561A Antimigraine cyclobutenedione derivatives of indolylalkyl-pyridinyl and pyrimidinylpiperazines
11/29/1995CN1112554A Derivative of 1-|2-(1H-indene-3-yl)ethyl¨-4-(naphthalene-1-yl)-piperazine and preparation and application of same
11/28/1995US5470977 Serotonin 1A receptor agonists
11/28/1995US5470871 Therapeutic compositions based on 1,2-dithiole-3-thione derivatives
11/28/1995US5470859 Azabicyclic compounds with muscarinic activity useful for treating dementia
11/28/1995US5470856 Tetrahydropyrimidine derivatives
11/28/1995US5470844 Heterocyclic-NMDA antagonists
11/28/1995CA2091986C Certain cycloalkyl and azacycloalkyl pyrrolopyrimidines; a new class of gaba brain receptor ligands
11/28/1995CA2023018C 2-oxo-3,8-diazaspiro /4,5/decane derivatives, pharmaceutical compositions containing them and process for preparing the same
11/28/1995CA1337659C Optical isomers of an imidazole derivative
11/23/1995WO1995031566A1 Compositions and methods for targeting gene delivery vehicles
11/23/1995WO1995031543A1 Dna encoding the beta subunit of a mammalian 'maxi-k' potassium channel
11/23/1995WO1995031539A1 Neurotransmitter transporter
11/23/1995WO1995031464A1 New agonist compounds
11/23/1995WO1995031463A1 New antagonist compounds
11/23/1995WO1995031457A1 Derivatives of quinuclidine n-oxide as muscarinic receptor ligands
11/23/1995WO1995031443A1 Acid amide derivatives and process for the preparation thereof
11/23/1995WO1995031197A1 Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor
11/23/1995WO1995031195A1 Use of no scavengers, inhibitors or antagonists in the treatment of migraine
11/23/1995WO1995031182A1 Narcotic containing aerosol formulation
11/23/1995WO1995029257A3 Apolipoprotein e polymorphism and treatment of alzheimer's disease
11/23/1995CA2190532A1 Acid amide derivatives and process for the preparation thereof
11/23/1995CA2189761A1 Dna encoding the beta subunit of a mammalian "maxi-k" potassium channel
11/23/1995CA2189528A1 Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor
11/23/1995CA2189139A1 New agonist compounds
11/23/1995CA2158926A1 Compositions and methods for targeting gene delivery vehicles
11/22/1995EP0683172A1 11,21-Bisphenyl-19-norpregnane derivatives
11/22/1995EP0683168A1 Method for producing 2-methylspiro(1,3-oxathiolane-5,3')quinuclidine
11/22/1995EP0683166A1 3-Indolylpiperidines
11/22/1995EP0683155A1 Tetrahydrobenz cd indoles with serotonin regulatory activity
11/22/1995EP0682657A1 9H-INDENO[1,2-b]PYRAZINE-3(4H)-ONES AND 9H-INDENO[1,2-b]PYRAZINE-2,3(1H,4H)-DIONES AND THEIR PREPARATION AND USE
11/22/1995EP0682656A1 Use of phenyl heteroaryl ureas as 5ht 2c? receptor antagonists and urea compounds
11/22/1995EP0682526A1 PULMONARY ADMINISTRATION OF sCR1 AND OTHER COMPLEMENT INHIBITORY PROTEINS
11/22/1995EP0682515A1 Use of inhibitors of ornithine aminotransferase for the manufacture of a medicament for the treatment of alzheimer's disease
11/22/1995EP0682514A1 Use of topical anesthetics for the manufacture of a medicament for the treatment of bronchial asthma
11/22/1995EP0607355B1 3-ureido-benzodiazepinones useful as antagonists of cck or of gastrine
11/22/1995EP0544714B1 Heterocyclic compounds and their preparation and use
11/22/1995CN1112118A Epi-epibatidine derivatives
11/22/1995CN1112114A Novel aminoalkyl benzoxazolinones and benzothiazolinones process for their preparation and the pharmaceutical compositions which contain them
11/22/1995CN1111986A Isoxazole derivatives for the treatment of irritable bowels syndrome
11/21/1995USRE35095 Treatment of epileptic seizure in mammals
11/21/1995US5468898 Antiinflammatory agents, antiarthritic agents, treatment for gastrointestinal disorders, psoriasis
11/21/1995US5468872 Nerve growth factor
11/21/1995US5468768 For treating vascular headaches
11/21/1995US5468766 Analgesics, antipyretics, antiphlogistics
11/21/1995US5468758 5-HT antagonists
11/21/1995US5468753 Use of a 1-(2-naphthylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine for the manufacture of a medicament for the treatment of cerebral and neuronal diseases
11/21/1995US5468748 Nervous system and psychological disorders; antagonize glycine binding site on N-methylaspartic acid receptor complex
11/21/1995US5468744 Composition comprising a tramadol material and any of codeine, oxycodone or hydrocodone and their use
11/21/1995CA2033480C Indolyl-3 polyamines useful as antagonists of excitatory amino acid neurotransmitters
11/19/1995CA2149608A1 Tetrahydrobenz¬cd|indazoles
11/16/1995WO1995030900A1 MODULATORS OF CYTOKINES OF THE TGF-β SUPERFAMILY AND METHODS FOR ASSAYING FOR SAME
11/16/1995WO1995030694A1 New opioid peptide analogs with mixed mu agonist/delta antagonist properties
11/16/1995WO1995030687A1 Neurokinine (tachykinine) antagonists
11/16/1995WO1995030683A1 Adenosine derivatives
11/16/1995WO1995030675A1 Biphenylcarboxamides useful as 5-ht1d antagonists
11/16/1995WO1995030674A1 Morpholine derivatives and their use as antagonists of tachikinins
11/16/1995WO1995030645A1 Amide derivatives and their therapeutic use
11/16/1995WO1995030644A1 Amide derivatives and their therapeutic use
11/16/1995WO1995030641A1 Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic acitivities
11/16/1995WO1995030640A1 Substituted fused and bridged bicyclic compounds as therapeutic agents
11/16/1995WO1995030435A2 Compositions and treatment for multiple sclerosis
11/16/1995WO1995030433A1 A novel brain endothelial cell protein and methods for its use
11/16/1995WO1995030432A1 Use of chondroitin sulphate proteoglycans for protection of neurons
11/16/1995WO1995030431A1 Method for reduction of headache pain
11/16/1995WO1995030430A1 Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent
11/16/1995WO1995028418A3 Tachykinin antagonists
11/16/1995CA2312047A1 Method for reduction of headache pain
11/16/1995CA2190027A1 A novel brain endothelial cell protein and methods for its use
1 ... 1660 1661 1662 1663 1664 1665 1666 1667 1668 1669 1670 1671 1672 1673 1674 1675 1676 1677 1678 1679 1680 ... 1833